According to the publisher, Latin America diabetes devices market size is expected to record a CAGR of 5.9% during 2023-2027 to reach US$9.152 billion by 2027, increasing from US$6.872 billion in 2023. Over the last five years, the sector has recorded a CAGR of 6.3% to reach US$6.463 billion in 2022.
This offering is a bundled offering, combining 4 countries and a key report covering Latin America.This report provides an in-depth data-centric analysis of the emerging opportunities in the diabetes devices and therapeutics industry. It covers a detailed view of market size and forecast across various segments such as by category, diagnosis and monitoring devices, therapeutics, route of administration, type of diabetes, distribution channels, and end users.
This offering is a bundled offering, combining 4 countries and a key report covering Latin America.This report provides an in-depth data-centric analysis of the emerging opportunities in the diabetes devices and therapeutics industry. It covers a detailed view of market size and forecast across various segments such as by category, diagnosis and monitoring devices, therapeutics, route of administration, type of diabetes, distribution channels, and end users.
This title is a bundled offering, combining the following 5 reports, covering 160+ tables and 212+ figures:
- Country Report 1 - Latin America Diabetes Devices and Therapeutics Business Opportunities Databook - Q2 2023 Update
- Country Report 2 - Brazil Diabetes Devices and Therapeutics Business Opportunities Databook - Q2 2023 Update
- Country Report 3 - Argentina Diabetes Devices and Therapeutics Business Opportunities Databook - Q2 2023 Update
- Country Report 4 - Colombia Diabetes Devices and Therapeutics Business Opportunities Databook - Q2 2023 Update
- Country Report 5 - Mexico Diabetes Devices and Therapeutics Business Opportunities Databook - Q2 2023 Update
Scope
This report provides an in-depth, data-centric analysis of the Latin America diabetes devices and therapeutics market 2018-2027. Below is a summary of key market segments:Diabetes Devices and Therapeutics Market Share by Category
- Diagnosis and Monitoring Devices
- Therapeutics
Diabetes Devices and Therapeutics Market Share by Diagnosis and Monitoring Devices
- Blood Glucose Monitoring Devices
- Insulin Delivery Devices
- Diabetes Management and Mobile Applications
- Artificial Pancreas Devices
Diabetes Devices and Therapeutics Market Share by Blood Glucose Monitoring Devices
- Self-Monitoring Blood Glucose Devices
- Continuous Blood Glucose Monitoring Devices
- Test Strips
- Lancets
Diabetes Devices and Therapeutics Market Share by Insulin Delivery Devices
- Insulin Pumps
- Insulin Pens
- Insulin Syringes
Diabetes Devices and Therapeutics Market Share by Therapeutics
- Oral Anti-Diabetic Drugs
- Insulin
- Non-Insulin Injectable Drugs
- Combination Drugs
Diabetes Devices and Therapeutics Market Share by Oral Anti-Diabetic Drugs
- Alpha-Glucosidase Inhibitors
- DPP-4 Inhibitors
- SGLT-2 Inhibitors
Diabetes Devices and Therapeutics Market Share by Insulin
- Basal or Long-Acting
- Bolus or Fast-Acting
- Traditional Human Insulin Drugs
- Insulin Biosimilars
Diabetes Devices and Therapeutics Market Share by Non-Insulin Injectable Drugs
- GLP-1 Receptor Agonists
- Amylin Analogue
Diabetes Devices and Therapeutics Market Share by Combination Drugs
- Combination Insulin
- Oral Combination
Diabetes Devices and Therapeutics Market Share by Route of Administration
- Subcutaneous
- Intravenous
- Others
Diabetes Devices and Therapeutics Market Share by Type of Diabetes
- Type 1 Diabetes
- Type 2 Diabetes
Diabetes Devices and Therapeutics Market Share by Distribution Channels
- Online Pharmacies
- Hospital Pharmacies
- Retail Pharmacies
Diabetes Devices and Therapeutics Market Share by End User
- Hospitals
- Diabetes Clinics
- Homecare
Reasons to buy
- In-depth understanding of diabetes devices and therapeutics market dynamics: Understand market opportunity, industry dynamics, key trends, and drivers across different market segments and sub-segments of the industry in Latin America.
- Develop market-specific strategies: Identify growth segments and target specific opportunities to formulate your investment strategy; assess market-specific key trends, drivers, and risks in the industry.
- Get market share analysis by end users: Get a detailed analysis across different end users such as hospitals, diabetes clinics, and homecare within the Latin America.
Table of Contents
This title is a bundled offering, combining the following 5 reports, covering 160+ tables and 212+ figures:
1 About this Report
3 Diabetes Devices and Therapeutics Market Share by Category, 2018-2027
4 Diabetes Devices and Therapeutics Market Share by Diagnosis and Monitoring Devices, 2018-2027
5 Diabetes Devices and Therapeutics Market Share by Blood Glucose Monitoring Devices, 2018-2027
6 Diabetes Devices and Therapeutics Market Share by Insulin Delivery Devices, 2018-2027
7 Diabetes Devices and Therapeutics Market Share by Therapeutics, 2018-2027
8 Diabetes Devices and Therapeutics Market Share by Oral Anti-Diabetic Drugs, 2018-2027
9 Diabetes Devices and Therapeutics Market Share by Insulin, 2018-2027
10 Diabetes Devices and Therapeutics Market Share by Non-Insulin Injectable Drugs, 2018-2027
11 Diabetes Devices and Therapeutics Market Share by Combination Drugs, 2018-2027
12 Diabetes Devices and Therapeutics Market Share by Route of Administration, 2018-2027
13 Diabetes Devices and Therapeutics Market Share by Type of Diabetes, 2018-2027
14 Diabetes Devices and Therapeutics Market Share by Distribution Channels, 2018-2027
15 Diabetes Devices and Therapeutics Market Share by End User, 2018-2027
16 Further Reading
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 300 |
Published | August 2023 |
Forecast Period | 2023 - 2027 |
Estimated Market Value ( USD | $ 6.87 Billion |
Forecasted Market Value ( USD | $ 9.15 Billion |
Compound Annual Growth Rate | 5.8% |
Regions Covered | Latin America |